AXGN Q4 2020 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$32M+15.4% YoY

Gross Profit

$27M83.2% margin

Operating Income

-$5M-16.5% margin

Net Income

-$6M-18.5% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-2.8%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

-$161,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$201M

Total Liabilities

$78M

Stockholders' Equity

$123M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$28M	+15.4%
Gross Profit	$27M	$23M	+16.1%
Operating Income	-$5M	-$7M	+27.6%
Net Income	-$6M	-$7M	+14.6%